Home › Digestive Diseases › Tennessee
Digestive Diseases clinical trials in Tennessee
6 studies for Digestive Diseases are looking for participants at sites in Tennessee.
Cities in Tennessee
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Sep 29, 2026 · NCT07197944Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Henry-Joyce Cancer Clinic, Nashville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222800Product Surveillance Registry
- Germantown
- Memphis
- Nashville
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Cordova
- 89bio Clinical Study Site, Hermitage
- 89bio Clinical Study Site, Nashville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chattanooga
- 89bio Clinical Study Site, Cordova
- 89bio Clinical Study Site, Hermitage
- and 1 more
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 22 · All sexes · Updated Jul 20, 2026 · NCT05664113From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.